PetMed Express, Inc. (PETS)
|Net Income (ttm)||30.60M|
|Trading Day||July 30|
|Day's Range||29.76 - 31.43|
|52-Week Range||24.75 - 55.98|
PetMed Express Inc (NASDAQ: PETS) has reported a Q1 EPS of $0.22, lagging the consensus of 0.36 and lower than $0.39 posted a year ago. Net sales were $79.3 million, down 18% Y/Y and far below the conse...
PetMed Express, Inc. d/b/a 1-800-PetMeds Announces Its First Quarter Financial Results and a Quarterly Dividend of $0...
DELRAY BEACH, Fla., July 26, 2021 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for its first quarter ended June 30, 2021. Net sales for the quarter ended...
DELRAY BEACH, Fla., July 19, 2021 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) will announce its financial results for the quarter ended June 30, 2021 on Monday, July 26, 2021 at 8:00 A.M. Ea...
PetMed Express, Inc. (NASDAQ:PETS) is an online pet pharmacy based in the United States, delivering pet medications and other health products for dogs, cats, and horses.
The Nasdaq led the market lower.
A surge in meme stocks and a short squeeze sent the online pet pharmacy soaring.
Today, short squeeze interest is driving the stock prices of heavily shorted stocks such as PETS stock dramatically higher on high volume. The post PETS Stock: 9 Things to Know About Short-Squeeze Play ...
While the market has taken a beating over recent days, pullbacks are the mother's milk of effective investment strategies, and shrewd market participants will already have a growing shopping list on han...
The reopening of veterinary clinics and pet retailers caused lower sales for the online pet pharmacy.
Shares of PetMed Express (NASDAQ:PETS) moved higher by 1.8% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 2.86% over the past year to $0.34,...
PetMed Express, Inc. d/b/a 1-800-PetMeds Announces Its Fourth Quarter and Fiscal Year End Financial Results and Incre...
8.8% Increase in Fiscal 2021 Sales 18.4% Increase in Fiscal 2021 Net Income 9.7% Increase in Fiscal 2021 Reorder Sales
On Monday, May 03, PetMed Express (NASDAQ:PETS) will release its latest earnings report. Decipher the announcement with Benzinga's help.
DELRAY BEACH, Fla., April 26, 2021 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) will announce its financial results for the fiscal year ended March 31, 2021 on Monday, May 3, 2021 at 8:00 A.M...
Trailing double-digit revenue growth? Check. Off 30% to 45% from recent highs?
Pet stocks have performed very well recently, and many analysts believe that this trend will continue as the industry grows. The post 7 Pet Stocks for Animal Lovers and Investors Alike appeared first on...
The short squeeze mania continued.
From pet health to tech to grocery stores, these stocks can seriously diversify your portfolio -- and give you a dividend boost.
PetMed Express has the only attractive yield in the pet stock universe and has no debt. It has lagged other pet stocks and looks undervalued
Shares of online pet pharmacy retailer PetMed Express Inc. (NASDAQ:PETS) plunged more than 12% on Tuesday following the release of its third-quarter results. The Delray Beach, Florida-based company anno...
Shares of the online pet pharmacy pulled back after it reported earnings this morning.
PetMed Express Inc. stock slumped 8.6% in Tuesday premarket trading before rebounding to a 2.1% decline after the pet pharmacy reported fiscal third-quarter profit that missed expectations. Net income t...
Stocks concluded the day on Friday logging both daily losses across the board after President-elect Joe Biden's announcement of a $1.9 trillion rescue plan failed to give investors the sentiment boost t...
Rising pet ownership rates and a steadily increasing average household spending provide a powerful tailwind to this investment theme. Pet food, animal health, veterinary equipment, and specialized e-com...
Americans love their pets, and no pandemic, not even the novel coronavirus, will change that, bolstering these eight pet stocks. The post 8 Pet Stocks That Will Make You Purr appeared first on InvestorP...
Prescription sales are driving profitability. Orders showing YoY growth for three Quarters.
PetsMed Express reported its fiscal Q2 earnings highlighted by firming margins and higher earnings. The stock has been volatile in recent months considering more subdued expectations compared to a stron...
PetMed Express (PETS) on Q2 2020 Results - Earnings Call Transcript
Shares of PetMed Express (NASDAQ:PETS) rose 0.7% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 27.27% over the past year to $0.42, which beat the...
PetMed Express d/b/a 1-800-PetMeds Announces Its Second Fiscal Quarter Financial Results and Its Quarterly Dividend o...
Diluted EPS $0.42 vs $0.33 per share Quarterly Reorder Sales Increased 9.6% Gross Margins Improved Sequentially from 27.8% to 30.5%
PetMed Express D/B/A 1-800-PetMeds To Announce Its Second Quarter Financial Results On October 26, 2020
DELRAY BEACH, Fla., Oct. 19, 2020 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) will announce its financial results for the quarter ended September 30, 2020 on Monday, October 26, 2020 at 8:00...
PETS has come within one standard deviation of its 160-week moving average, a historically bullish trendline that could signal more upside for the stock.
Nate Pile — the editor of growth stock advisory Nate's Notes has just released the first issue of a new advisory service focused on retirement investing, The Little River Investment Guide. The advisor r...
PetMed Express (PETS) earnings for the online pet pharmacy company's fiscal first quarter of 2020 have PETS stock falling on Monday.
The pet pharmacy delivered solid revenue and earnings growth. But its bottom-line improvement wasn't quite good enough to impress analysts.
PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventative... [Read more...]
|Stock Exchange |
|Ticker Symbol |
In 2020, PetMed Express's revenue was $309.22 million, an increase of 8.83% compared to the previous year's $284.13 million. Earnings were $30.60 million, an increase of 18.38%.
According to 2 analysts, the average rating for PetMed Express stock is "Sell." The 12-month stock price forecast is 31.50, which is an increase of 0.35% from the latest price.